Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -52.34% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -39.25%. Over the past 30 days, the price of RVPH has leaped by -19.37%. And in the last five days, it has surged by 14.43%.
Reviva Pharmaceuticals Holdings Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $4.28 on 12/09/24 and the lowest value was $0.49 on 04/04/25.
52-week price history of RVPH Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Reviva Pharmaceuticals Holdings Inc’s current trading price is -79.84% away from its 52-week high, while its distance from the 52-week low is 77.88%. The stock’s price range during this period has varied between$0.49 and $4.28. The Reviva Pharmaceuticals Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.66 million for the day, a figure considerably lower than their average daily volume of 1.06 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Reviva Pharmaceuticals Holdings Inc (RVPH) has experienced a quarterly decline of -55.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 40.32M and boasts a workforce of 14 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4663, with a change in price of -0.2873. Similarly, Reviva Pharmaceuticals Holdings Inc recorded 2,176,805 in trading volume during the last 100 days, posting a change of -24.98%.
RVPH’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RVPH stands at 0.57. Similarly, the long-term debt-to-equity ratio is also 0.00.
RVPH Stock Stochastic Average
As of today, Reviva Pharmaceuticals Holdings Inc’s raw stochastic average for the last 50 days stands at 24.00%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 54.95%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 44.21% and 41.96%, respectively.
